00082sek
-8,9 %
Date:2024-10-22Time:17:29:00Latest report:Q2-2024List:First NorthTicker:DEV
Market Cap:11 msekEnterprise Value:11 msekNet Sales:22,9 msekEarnings:-18,4 msekEmployees:0ISIN:SE0015660345

Ratios

10-year key figure history for Deversify Health turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Deversify Health with index and moving average MA50 and MA200.

Stockprice:0,0082
MA50:0,02
MA200:0,06
Price/MA200:-85,4 %
RSI (14):25,8
Price/MA50:-62,0 %

Description

Deversify was founded in 2016 and has operations in Uppsala and Söderhamn. Deversify is a Swedish development company that offers technical solutions to measure health markers for consumers on a global market. The company has two business areas. The first business area develops and commercializes mobile electronic devices and mobile applications to monitor biomarkers for individualized health. Deversify specializes in exhalation meters and Deversify's exhalation meter Acetrack is currently marketed and sold in the area. In the other business area, Deversify develops and provides educational services in metabolic health and individualized nutrition counseling through the Elitista brand.

IT Services